Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Muraglitazar vs Pioglitazone in Type 2 Diabetes
NCT00106808Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of muraglitazar in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Aug 2005; status: completed.
02
Drugs
muraglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00106808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106808.